Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3233
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05568225 | A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS) | ||
| NCT04542642 | A Remote, Decentralized Opioid Use Disorder Study to Evaluate Patient Engagement With a Game-Based Digital Therapeutic | ||
| NCT05609812 | Atacicept in Subjects With Active Lupus Nephritis (COMPASS) | ||
| NCT07185880 | A Phase 1 Study of the Safety and Tolerability of MT-125 in GBM Patients | ||
| NCT02771340 | Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma | ||
| NCT05567770 | ACTInium-J591 Radionuclide Therapy in PSMA-Detected Metastatic HOrmone-Sensitive Recurrent Prostate CaNcer | ||
| NCT06251310 | SW-682 in Advanced Solid Tumors | ||
| NCT01706523 | Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders | ||
| NCT06437223 | Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC) | ||
| NCT03059446 | Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis | ||
| NCT01254890 | Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome | ||
| NCT01649388 | A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients | ||
| NCT00174980 | Study of Oxycyte in Severe Closed Head Injury | ||
| NCT05242718 | Immune Diversity Response to Oral Dosing of Nutritional Health Products in Healthy Participants | ||
| NCT04411680 | Study of Sargramostim in Patients With COVID-19 | ||
| NCT04772235 | Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients | ||
| NCT06447025 | An Open Label Extension Study of CTI-1601 in Subjects With Friedreich's Ataxia | ||
| NCT03282591 | Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough | ||
| NCT04105959 | A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model | ||
| NCT05885464 | A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) | ||
| NCT05500508 | Oral AMXT 1501 Dicaprate in Combination With IV DFMO | ||
| NCT06872125 | A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome | ||
| NCT04089189 | Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer | ||
| NCT06394518 | Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants | ||
| NCT03928184 | A Study Utilizing Patient-Reported and Radiographic Outcomes and Evaluating the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis | ||
| NCT04633148 | Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker | ||
| NCT04019704 | A Trial of AXS-05 in Patients With Major Depressive Disorder | ||
| NCT05881408 | A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) | ||
| NCT04268784 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL343 in Healthy Volunteers | ||
| NCT04341948 | Treatment of Post-Operative Pain Following Orthopedic Surgery With SPRINT® Peripheral Nerve Stimulation (PNS) System | ||
| NCT05913232 | Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension | ||
| NCT04311515 | To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia | ||
| NCT02427308 | Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry | ||
| NCT04962009 | Safety and Intraocular Lowering Effect of Delivery of Travoprost Evolute® in Subjects With Elevated Intraocular Pressure | ||
| NCT07007052 | Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients | ||
| NCT04056299 | Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy | ||
| NCT03054363 | Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer | ||
| NCT06223009 | Phase 1 Healthy Volunteer Burn Therapy Study | ||
| NCT03654716 | Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer | ||
| NCT07032285 | Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas | ||
| NCT03544060 | Volanesorsen Early Access Program for Patients With Familial Chylomicronemia Syndrome (FCS) | ||
| NCT01966224 | A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects | ||
| NCT02724527 | Study of Cavosonstat (N91115) in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated With Ivacaftor | ||
| NCT03637361 | Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of REL-1017 (d-Methadone) | ||
| NCT03932513 | Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients | ||
| NCT07215923 | A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers | ||
| NCT03236662 | (-)- Epicatechin Becker Muscular Dystrophy | ||
| NCT04706962 | TH1902 in Patients With Advanced Solid Tumors | ||
| NCT04064125 | Dermal Cumulative Irritant Patch Study | ||
| NCT02751359 | Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers |
